Gw Henssler & Associates LTD Has Decreased Its Visa (V) Stake; Dare Bioscience (DARE) Shorts Down By 2.32%

February 20, 2018 - By Maria Brooks

Dare Bioscience Incorporated (NASDAQ:DARE) had a decrease of 2.32% in short interest. DARE’s SI was 172,800 shares in February as released by FINRA. Its down 2.32% from 176,900 shares previously. With 68,700 avg volume, 3 days are for Dare Bioscience Incorporated (NASDAQ:DARE)’s short sellers to cover DARE’s short positions. The stock decreased 1.43% or $0.02 during the last trading session, reaching $1.38. About 780,254 shares traded or 165.02% up from the average. Daré Bioscience, Inc. (NASDAQ:DARE) has 0.00% since February 20, 2017 and is . It has underperformed by 16.70% the S&P500.

Gw Henssler & Associates Ltd decreased Visa Inc (V) stake by 2.75% reported in 2017Q3 SEC filing. Gw Henssler & Associates Ltd sold 4,088 shares as Visa Inc (V)’s stock rose 5.74%. The Gw Henssler & Associates Ltd holds 144,406 shares with $15.20 million value, down from 148,494 last quarter. Visa Inc now has $275.00 billion valuation. The stock decreased 0.35% or $0.43 during the last trading session, reaching $121.85. About 6.37M shares traded. Visa Inc. (NYSE:V) has risen 20.29% since February 20, 2017 and is uptrending. It has outperformed by 3.59% the S&P500.

Daré Bioscience, Inc. develops and commercializes product for women’s reproductive health, Ovaprene. The company has market cap of $16.29 million.

Among 42 analysts covering Visa Inc. (NYSE:V), 34 have Buy rating, 0 Sell and 8 Hold. Therefore 81% are positive. Visa Inc. had 125 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Thursday, October 22 by Wells Fargo. The stock of Visa Inc. (NYSE:V) earned “Buy” rating by Loop Capital on Wednesday, February 15. Loop Capital maintained the shares of V in report on Thursday, October 26 with “Buy” rating. RBC Capital Markets maintained the shares of V in report on Thursday, January 4 with “Buy” rating. The rating was initiated by Sterne Agee CRT with “Buy” on Thursday, December 17. The company was maintained on Thursday, January 4 by Mizuho. RBC Capital Markets maintained the shares of V in report on Thursday, February 1 with “Buy” rating. The stock of Visa Inc. (NYSE:V) has “Outperform” rating given on Thursday, January 25 by Oppenheimer. The stock has “Outperform” rating by Oppenheimer on Monday, October 19. On Friday, July 14 the stock rating was maintained by Cowen & Co with “Buy”.

Investors sentiment decreased to 1 in 2017 Q3. Its down 0.13, from 1.13 in 2017Q2. It fall, as 48 investors sold V shares while 617 reduced holdings. 142 funds opened positions while 524 raised stakes. 1.64 billion shares or 1.45% less from 1.66 billion shares in 2017Q2 were reported. Montecito Natl Bank reported 0.48% stake. First Midwest Commercial Bank Tru Division owns 39,913 shares. Levin Strategies Ltd Partnership invested in 2,885 shares or 0.01% of the stock. Virtu Ltd, New York-based fund reported 22,060 shares. Klingenstein Fields Communication Limited Liability accumulated 23,190 shares. Tocqueville Asset Mngmt LP accumulated 283,197 shares. Riverhead Cap Management Ltd Llc reported 0.18% stake. The Ontario – Canada-based Manufacturers Life Company The has invested 0.68% in Visa Inc. (NYSE:V). Boothbay Fund Management Limited Liability holds 0.14% of its portfolio in Visa Inc. (NYSE:V) for 8,100 shares. Amer Commercial Bank reported 2.23% in Visa Inc. (NYSE:V). Seatown Holdings Pte Ltd has invested 3.66% in Visa Inc. (NYSE:V). Whittier Trust Of Nevada invested in 114,532 shares. Brown Advisory Securities Ltd Llc reported 1.52% of its portfolio in Visa Inc. (NYSE:V). Oregon-based Oregon Public Employees Retirement Fund has invested 0.76% in Visa Inc. (NYSE:V). Ngam Advisors Lp owns 1.49M shares for 1.66% of their portfolio.

Since December 13, 2017, it had 0 insider purchases, and 3 insider sales for $6.56 million activity. MATSCHULLAT ROBERT W sold $707,561 worth of Visa Inc. (NYSE:V) on Wednesday, December 13. $5.65M worth of Visa Inc. (NYSE:V) was sold by MAHON TULLIER KELLY. Biggar Lynne sold $205,440 worth of stock.

Gw Henssler & Associates Ltd increased Abbott Labs (NYSE:ABT) stake by 7,344 shares to 254,889 valued at $13.60 million in 2017Q3. It also upped Lockheed Martin Corp (NYSE:LMT) stake by 1,354 shares and now owns 27,555 shares. Claymore Exchange Trd Fd Tr (BSJK) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts